Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Health disparities and treatment approaches in portopulmonary hypertension and idiopathic pulmonary arterial hypertension: an analysis of the Pulmonary Hypertension Association Registry.
DuBrock HM, Burger CD, Bartolome SD, Feldman JP, Ivy DD, Rosenzweig EB, Sager JS, Presberg KW, Mathai SC, Lammi MR, Klinger JR, Eggert M, De Marco T, Elwing JM, Badesch D, Bull TM, Cadaret LM, Ramani G, Thenappan T, Ford HJ, Al-Naamani N, Simon MA, Mazimba S, Runo JR, Chakinala M, Horn EM, Ryan JJ, Frantz RP, Krowka MJ. DuBrock HM, et al. Among authors: bartolome sd. Pulm Circ. 2021 May 17;11(3):20458940211020913. doi: 10.1177/20458940211020913. eCollection 2021 Jul-Sep. Pulm Circ. 2021. PMID: 34158918 Free PMC article.
Macitentan and morbidity and mortality in pulmonary arterial hypertension.
Pulido T, Adzerikho I, Channick RN, Delcroix M, Galiè N, Ghofrani HA, Jansa P, Jing ZC, Le Brun FO, Mehta S, Mittelholzer CM, Perchenet L, Sastry BK, Sitbon O, Souza R, Torbicki A, Zeng X, Rubin LJ, Simonneau G; SERAPHIN Investigators. Pulido T, et al. N Engl J Med. 2013 Aug 29;369(9):809-18. doi: 10.1056/NEJMoa1213917. N Engl J Med. 2013. PMID: 23984728 Free article. Clinical Trial.
Inflammatory bowel diseases, chronic liver diseases and the lung.
Rodriguez-Roisin R, Bartolome SD, Huchon G, Krowka MJ. Rodriguez-Roisin R, et al. Among authors: bartolome sd. Eur Respir J. 2016 Feb;47(2):638-50. doi: 10.1183/13993003.00647-2015. Epub 2016 Jan 21. Eur Respir J. 2016. PMID: 26797027 Free article. Review.
Predictors of Waitlist Mortality in Portopulmonary Hypertension.
DuBrock HM, Goldberg DS, Sussman NL, Bartolome SD, Kadry Z, Salgia RJ, Mulligan DC, Kremers WK, Kawut SM, Krowka MJ, Channick RN. DuBrock HM, et al. Among authors: bartolome sd. Transplantation. 2017 Jul;101(7):1609-1615. doi: 10.1097/TP.0000000000001666. Transplantation. 2017. PMID: 28207639 Free PMC article.
Portopulmonary Hypertension: A Survey of Practice Patterns and Provider Attitudes.
DuBrock HM, Salgia RJ, Sussman NL, Bartolome SD, Kadry Z, Mulligan DC, Jenkins S, Lackore K, Channick RN, Kawut SM, Krowka MJ. DuBrock HM, et al. Among authors: bartolome sd. Transplant Direct. 2019 May 22;5(6):e456. doi: 10.1097/TXD.0000000000000900. eCollection 2019 Jun. Transplant Direct. 2019. PMID: 31321292 Free PMC article.
Ambrisentan in portopulmonary hypertension: A multicenter, open-label trial.
Preston IR, Burger CD, Bartolome S, Safdar Z, Krowka M, Sood N, Ford HJ, Battarjee WF, Chakinala MM, Gomberg-Maitland M, Hill NS. Preston IR, et al. J Heart Lung Transplant. 2020 May;39(5):464-472. doi: 10.1016/j.healun.2019.12.008. Epub 2020 Jan 21. J Heart Lung Transplant. 2020. PMID: 32008947 Clinical Trial.
BMP9/10 in Pulmonary Vascular Complications of Liver Disease.
Rochon ER, Krowka MJ, Bartolome S, Heresi GA, Bull T, Roberts K, Hemnes A, Forde KA, Krok KL, Patel M, Lin G, McNeil M, Al-Naamani N, Roman BL, Yu PB, Fallon MB, Gladwin MT, Kawut SM. Rochon ER, et al. Am J Respir Crit Care Med. 2020 Jun 15;201(12):1575-1578. doi: 10.1164/rccm.201912-2514LE. Am J Respir Crit Care Med. 2020. PMID: 32083953 Free PMC article. No abstract available.
Estrogen Signaling and Portopulmonary Hypertension: The Pulmonary Vascular Complications of Liver Disease Study (PVCLD2).
Al-Naamani N, Krowka MJ, Forde KA, Krok KL, Feng R, Heresi GA, Dweik RA, Bartolome S, Bull TM, Roberts KE, Austin ED, Hemnes AR, Patel MJ, Oh JK, Lin G, Doyle MF, Denver N, Andrew R, MacLean MR, Fallon MB, Kawut SM; , for the Pulmonary Vascular Complications of Liver Disease Study Group. Al-Naamani N, et al. Hepatology. 2021 Feb;73(2):726-737. doi: 10.1002/hep.31314. Epub 2020 Sep 29. Hepatology. 2021. PMID: 32407592 Free PMC article.
47 results